An open label single arm study to investigate the safety and efficacy of multiple administartions of NI-0801, a fully human anti-CXCL 10 monoclonal antibody in primary biliary cirrhosis patients with an incomplete response to ursodeoxycholic acid. (PIANO)

1st September 2011

Status: Ended

Specialism:

Team: Dr Steve Ryder.

People
Photo Name Bio
dr-steve-ryder Dr Steve Ryder
Publications
Title
Grants
Title Amount